This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Pharma And BioTech News Podcasts
Pharmaceutical and biotech news in 5 minutes. Drug approvals, clinical trials, and healthcare innovation.
…
continue reading
BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries. Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences. Disclaimer https://biobizbuzz.com/disclaimer/
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
…
continue reading
News and Analysis of the Biotech and Pharma Industry for Investors and Executives.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Welcome to the Ennovation Podcast, where we bring you the latest trends, insights and expertise in life sciences and regulatory affairs.
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
1
Healthcare NOW Radio Podcast Network - Discussions on healthcare including technology, innovation, policy, data security, telehealth and more. Visit HealthcareNOWRadio.com
Healthcare NOW Radio and Podcast Network - Radio and Podcasts for the Healthcare Industry
47
4k
RADIO FOR THE HEALTHCARE INDUSTRY Healthcare NOW Radio and Podcast Network offers discussions on the latest developments and trends impacting the industry including: health tech, health IT, healthcare innovation, healthcare policy, healthcare data security, telehealth, interoperability, biotech, med tech, value-based care, pharma, healthcare compliance, and much more. Shows are hosted by industry thought leaders. Guests are a "who's who" across the healthcare spectrum. The listening audience ...
…
continue reading
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
…
continue reading
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
…
continue reading
Join Hercules Capital in conversations with today’s top CEOs, CFOs, and investors in venture and private equity-backed companies. Learn about their strategies for financing rapid growth and scaling their businesses, as well as their unique interests and life stories that have shaped their paths to success.
…
continue reading
The Prospect Group is a leading global firm specializing in media, research, and consulting. We meet, and discuss the most relevant economic issues with, hundreds of the world’s leading business executives, political elites, and other influential personalities from a cross-section of industries and countries. Watch video interviews from and/or about Malaysia.
…
continue reading
This is Politics & Life Sciences (PLS) Radio which is an interplay of Life Sciences and Politics. I am your host Dean L. Fanelli, Ph.D. I am an Intellectual Property attorney in Washington, DC. My practice focuses on issues attendant to the Life Sciences industry. On PLS, we will explores cutting edge topics involving the Biotech and Pharma ecosystems and looks at political or governmental policy issues affecting the Biotech and Pharma industries. Each week, PLS will have amazing guests incl ...
…
continue reading
Are you working in healthcare market research or competitive intelligence or market intelligence? Do you often face information overload, from the pharma news portals, clinical trial registries, regulatory agencies, financial reports, investor releases, pharma summits, investment news, and financial summits etc.? It is hard to keep a track of all the forces (external and internal) that affects a product’s development and performance in the healthcare/ pharmaceutical market. We at RAS Life Sc ...
…
continue reading
1
374: Veteran biotech executive Clive Meanwell on drug pricing and the obesity market
34:10
34:10
Play later
Play later
Lists
Like
Liked
34:10
On this week’s episode of “The Readout LOUD”: an interview with veteran biotech executive and company founder Clive Meanwell. Pfizer recently acquired one of Meanwell’s companies, the obesity drug developer Metsera, for just under $5 billion. Meanwell offered his perspectives on the evolving obesity drug market, and continued need for drugs to trea…
…
continue reading
1
Pharma Breakthroughs: Advancing Cancer, Diabetes, and HIV Care
5:26
5:26
Play later
Play later
Lists
Like
Liked
5:26
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving into a series of major advancements and strategic moves that are shaping the future of healthcare.A significant development comes from AstraZeneca, which has committed a substantial $445 million in…
…
continue reading
1
Teaching the Pancreas to Heal Itself: Dr. Juan Domínguez-Bendala on Regenerative Diabetes Research
38:09
38:09
Play later
Play later
Lists
Like
Liked
38:09
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, spoke with Juan Domínguez-Bendala, PhD, Director of Stem Cell and Pancreatic Regeneration Programs, Diabetes Research Institute (DRI) at the University of Miami, to discuss his research team’s new research published in Nature…
…
continue reading
1
12. Revolution technology set to transform breast cancer diagnosis and treatment.
19:54
19:54
Play later
Play later
Lists
Like
Liked
19:54
Breast cancer affects women of all ages after puberty in every country. In 2022, the disease struck an estimated 2.3 million women and claimed 670 000 lives globally, according to the World Health Organization. The Global Breast Cancer Initiative (GBCI), is working to reduce breast cancer deaths by 2.5% each year, preventing 2.5 million deaths by 2…
…
continue reading
1
Navigating Regulatory Shifts and Strategic Mergers in Biotech
6:46
6:46
Play later
Play later
Lists
Like
Liked
6:46
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we explore the rapidly evolving landscape of the pharmaceutical and biotech sectors, where regulatory updates, strategic mergers, and scientific breakthroughs are continually reshaping the industry.Starting wit…
…
continue reading
1
Revolutionizing Care: Key Biotech Breakthroughs and Trends
7:34
7:34
Play later
Play later
Lists
Like
Liked
7:34
Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Let's dive into the latest news shaping this dynamic industry.Bristol Myers Squibb recently made headlines with their acquisition of Orbital Therapeutics for a remarkable $1.5 billion. This strategic move is aimed at …
…
continue reading
1
Revenue Cycle Optimized: Ensuring Quality and Compliance in AI Coding
40:12
40:12
Play later
Play later
Lists
Like
Liked
40:12
Ensuring Quality and Compliance in AI CodingExplore how today’s AI-powered coding solutions are designed with compliance and quality at their core. This episode will highlight the safeguards built into implementation, the auditing processes that protect accuracy, and how continuous improvement ensures models evolve over time. Join us to learn how o…
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on FDA Approvals, Breakthroughs, and More
2:08
2:08
Play later
Play later
Lists
Like
Liked
2:08
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. ##FDA Approves New Cancer TreatmentThe FDA has approved a new cancer treatment that has shown promising results in clinical trials. This treatment is expected to provide a new option for patients who have not respond…
…
continue reading
1
HealthLaw HotSpot: Estate Planning Essentials for Healthcare Professionals
18:02
18:02
Play later
Play later
Lists
Like
Liked
18:02
Host Ericka Adler is joined by Donna Hartl from the firm’s Tax Group to discuss why estate planning is essential for healthcare providers. Donna explains the basics of wills, trusts, and powers of attorney, highlighting how these tools help you avoid probate, protect your assets, and ensure your wishes are honored if you become incapacitated. The c…
…
continue reading
his Week in Review covers 5 episodes from October 06 to October 10, featuring major developments in the pharmaceutical and biotech industries. Episodes included: 1. Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates 2. Pharma and Biotech Daily: Top Stories in the Industry from Zenas to Lilly 3. Pharma and Biotech …
…
continue reading
1
Healthcare for Humans: Congo: When History Walks into Your Exam Room
44:43
44:43
Play later
Play later
Lists
Like
Liked
44:43
Episode 76 Congo: When History Walks into Your Exam RoomOn this episode host Raj Sundar sits down with Jean Jacques, physician, community organizer to explore how the long and complex history of the Democratic Republic of Congo—including colonialism, resource-driven conflict, and trauma—shapes the healthcare experience of Congolese immigrants and r…
…
continue reading
September News You Can UsePaging Dr. Common Sense, Your System Update Is OverdueTopics include: Vaccine guidance has shifted from “everyone over 6 months” to a confusing patchwork of rules, leaving doctors and patients scratching their heads; COVID and flu vaccines won’t stop infection but do reduce the risk of severe illness, hospitalization, and …
…
continue reading
1
The Healthtech Marketing Show: AI Quick Take: Marketing Leader to AI Agent Builder
41:34
41:34
Play later
Play later
Lists
Like
Liked
41:34
AI Quick Take – Marketing Leader to AI Agent BuilderOn this episode host Adam Turinas talks to Susan Roth, Senior Director of Marketing at Netrality Data Centers, about her remarkable journey from marketing leader to AI agent builder.Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more…
…
continue reading
1
Health Cent$: Eric Levin, CEO, Scripta Insights
28:57
28:57
Play later
Play later
Lists
Like
Liked
28:57
On this episode, host Adam Russo welcomes Eric Levin, CEO of Scripta Insights, a company that navigates you, and your members, to prescription savings. Eric explains how his company helps people save money on prescription drugs by comparing prices and offering alternatives.To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your…
…
continue reading
1
How Boehringer Ingelheim is buttressing its US business
18:36
18:36
Play later
Play later
Lists
Like
Liked
18:36
With a new president of U.S. pharma at the helm—and two key FDA approvals now in the books—Boehringer Ingelheim is sharpening its focus on the lucrative American market. In this week’s episode of “The Top Line,” we dive into Boehringer Ingelheim’s latest regulatory successes, two crucial launches, and the German company’s expanding commercializatio…
…
continue reading
1
Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates
0:51
0:51
Play later
Play later
Lists
Like
Liked
0:51
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world.Novo has recently completed the acquisition of Akero in a deal valued at up to $5.2 billion. This acquisition adds Akero's efruxifermin to Novo's already impressive portfolio. The FDA breakthrough drugs continue to sh…
…
continue reading
1
Contraline's ADAM in the clinic: towards a new era of male contraception?
40:33
40:33
Play later
Play later
Lists
Like
Liked
40:33
When it comes to contraception, most of the innovation in the last century has focused on providing contraceptive alternatives for women. The contraceptive pill was approved by the FDA in 1960, the first IUD approved in 1968, and the female condom in 1993. For men, however, there has been little advancement since the invention of the rubber condom …
…
continue reading
1
We Have TRUST Issues: Meet the hosts and welcome to the show
27:23
27:23
Play later
Play later
Lists
Like
Liked
27:23
S1E1: Hosts Tamer Baker and Steve Hajny introduce themselves and discuss what the show is about.Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/By Healthcare NOW Radio and Podcast Network - Radio and Podcasts for the Healthcare Industry
…
continue reading
1
Healthcare IT Today: Big Deal, Little Deal, No Deal
28:29
28:29
Play later
Play later
Lists
Like
Liked
28:29
Hosts Colin Hung and John Lynn discuss Big Deal, Little Deal, No Deal.To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”.Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen…
…
continue reading
1
Digital Health Talks: Measuring What Matters on ROI and Patient-Centered Technology in Healthcare
26:37
26:37
Play later
Play later
Lists
Like
Liked
26:37
Measuring What Matters: ROI and Patient-Centered Technology in HealthcareJoin us for an insightful conversation about the intersection of technology and healthcare with Pallavi Ranade from Intermountain Health and Janae Sharp. On this episode, they explore how healthcare organizations can effectively measure return on investment while keeping patie…
…
continue reading
1
373: Party in biotech land and AstraZeneca’s miscalculation
45:40
45:40
Play later
Play later
Lists
Like
Liked
45:40
Where did former vaccine regulator Peter Marks find a new job? How did a math error cost AstraZeneca a rare disease candidate? And is biotech back? We discuss all that on this week’s episode of the “The Readout LOUD,” STAT’s biotech podcast. We bring on Mizuho health care strategist Jared Holz to discuss the rebound in biotech stocks and sentiment.…
…
continue reading
1
11. A technological breakthrough in the diagnosis of skin cancer
26:14
26:14
Play later
Play later
Lists
Like
Liked
26:14
AI-based software solutions are increasingly being used as a second pair of eyes to help clinicians with the early diagnosis of diseases. With skin cancer seeing increasing rates of incidence and mortality, software solutions hold the key to helping clinicians with timely diagnosis. In this episode of BioBiz Buzz, your host Shani Alexander sits dow…
…
continue reading
1
Pharma and Biotech Daily: Top Stories in the Industry from Zenas to Lilly
1:46
1:46
Play later
Play later
Lists
Like
Liked
1:46
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Zenas has made a $2 billion bet on autoimmune diseases with Chinese firm InnoCare, focusing on the development of orelabrutinib for multiple sclerosis. Former FDA director Peter Marks has joined Eli Lilly, marking the compa…
…
continue reading
1
From Lab to Launch: Spinning out Biotech Innovation with RBL’s Dr. Paul Wotton
35:17
35:17
Play later
Play later
Lists
Like
Liked
35:17
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks.com, sits down with Paul Wotton, PhD, CEO of RBL LLC, a venture studio partially owned by Rice University. RBL’s mission is to transform groundbreaking research from the Rice Biotech LaunchPad into successful biotech startups. The…
…
continue reading
1
Pharma and Biotech Daily: Tariff Impact, Promising Trials, and Industry Leaders
1:30
1:30
Play later
Play later
Lists
Like
Liked
1:30
By Pharma Daily
…
continue reading
1
The CereCore Podcast: Ismelda Garza, Chief Information Officer, Cuero Regional Hospital
26:03
26:03
Play later
Play later
Lists
Like
Liked
26:03
Rolling Out EHRs in the Rural Setting: An Expert GuideHost: Phil Sobol, Chief Commercial Officer at CereCoreGuest: Ismelda Garza, Chief Information Officer, Cuero Regional HospitalFind all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/…
…
continue reading
1
Talking the Walk: Meet Heidi Health at HLTH 2025 in Las Vegas
27:19
27:19
Play later
Play later
Lists
Like
Liked
27:19
On this episode Tom Testa talks to Heidi Health's Director of North America, Jesse Creighton. Heidi and their AI scribe will be at hlth 2025 in Las Vegas at booth 3039. Jesse shares insights on Heidi and what you can expect to see in their booth. If you are attending hlth, stop by and see what they are up to.To stream our Station live 24/7 visit ww…
…
continue reading
1
Pharma and Biotech Daily: The Latest in Cell and Gene Therapy, M&A Activity, and Regulatory Updates
1:49
1:49
Play later
Play later
Lists
Like
Liked
1:49
By Pharma Daily
…
continue reading
1
Revenue Cycle Optimized: Bringing the Human Touch Back to AI Revenue Cycle Transformation
32:09
32:09
Play later
Play later
Lists
Like
Liked
32:09
Bringing the Human Touch Back to AI Revenue Cycle TransformationAI may be the buzzword of the decade, but its success depends on something far older—human connection. Join healthcare leader Nio Queiro for a candid discussion on demystifying AI, building trust across teams, and turning innovation into lasting operational change.Find all of our netwo…
…
continue reading
1
AI is changing drug safety, but governance sets the guardrails (Sponsored)
19:18
19:18
Play later
Play later
Lists
Like
Liked
19:18
By Fierce Life Sciences
…
continue reading
1
The Essential Updates in Pharma and Biotech: Your Daily Dose of What Matters
0:51
0:51
Play later
Play later
Lists
Like
Liked
0:51
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Former NIAID director Jeanne Marrazzo was fired after filing a whistleblower report, alleging retaliation. The FDA's new cell and gene therapy guidances have been well-received for streamlining therapies. In other news, CM…
…
continue reading
1
Ask the Educator: Shaver Study Data: Are your Seals Secure?
19:35
19:35
Play later
Play later
Lists
Like
Liked
19:35
Episode 146: Shaver Study Data: Are your Seals Secure?On this episode, Cheron Rojo talks to Kevin and Adam to recap Healthmark’s August 2025 webinar on his 2023 – 2024 arthroscopic shaver study and the results. Hear the sobering data on failure rates, where the issues were, contributing factors to the failures, and how can we start to improve these…
…
continue reading
1
The Healthtech Marketing Show: AI Cohort Research: State of AI in Healthtech Marketing
34:45
34:45
Play later
Play later
Lists
Like
Liked
34:45
AI Cohort Research – State of AI in Healthtech MarketingOn this episode host Adam Turinas talks to HEALTH Launchpad's team Mariana Small, Elena Putilina, and Amy Swanson about their irst-ever AI Cohort project. Hear about the healthcare marketing findings.Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe a…
…
continue reading
1
VBC Insights: The One Big Beautiful Bill Act: Leveraging Clinically Integrated Networks for Change
27:53
27:53
Play later
Play later
Lists
Like
Liked
27:53
The newly signed One Big Beautiful Bill Act is reshaping the healthcare landscape, with ripple effects for providers, payers, and patients. From Medicaid coverage shifts and rural hospital funding challenges to stricter ACA rules, expanded value-based care, and mandatory risk models, the implications are broad and far-reaching. On this episode Dan …
…
continue reading
1
Healthcare De Jure: Michael Coen and Michelle Skinner from TeleTracking
27:36
27:36
Play later
Play later
Lists
Like
Liked
27:36
Host Matt Fisher talks to Michael Coen, Chief Product & Technology Officer and Michelle Skinner, Chief Clinical Executive, TeleTracking about challenges in healthcare operations and patient flow; viewing flow as a form of logistics that requires coordination across a system and facilities; enabling efficient and effective flow with trusted data; im…
…
continue reading
1
Health UnaBASHEd: Gil Bashe, Chair Global Health and Purpose, FINN Partners
27:17
27:17
Play later
Play later
Lists
Like
Liked
27:17
On this episode executive producer Gregg Masters engages host Gil Bashe on his soon to be released (and titled) book. They tour innovation across the ecosystem landscape focusing on digital innovation, patient safety and improving performance in the healthcare delivery and finance space. To stream our Station live 24/7 visit www.HealthcareNOWRadio.…
…
continue reading
1
This Just In Radio: Beth Friedman, Sr Partner at FINN Partners
27:00
27:00
Play later
Play later
Lists
Like
Liked
27:00
Host Justin Barnes invites back his long time colleague and friend, Beth Friedman, Sr. Partner at FINN Voices. Justin and Beth discuss what is up for the Fall 2025 conference calendar and about the evolving value of in-person events. Beth shares insights on maximizing your impact as an organization attending events. To stream our Station live 24/7 …
…
continue reading
1
Trending NOW: Bob Lachance, CEO & Founder, REVA Global Medical
27:16
27:16
Play later
Play later
Lists
Like
Liked
27:16
S3E11: What's Trending NOW is how healthcare providers can reduce administrative burdens, avoid burnout, and scale their practices using trained virtual medical assistants. On this episode host Shahid Shah is joined by Bob Lachance, founder and CEO of REVA Global Medical, a company with Virtual Assistant solutions that empower healthcare profession…
…
continue reading
Tariffs, drug pricing reform, a government shutdown and a major turnover at one of the world’s largest drugmakers all converged this week, leaving plenty to unpack for the industry as it heads into fall. Greater clarity on President Donald Trump’s tariff and pricing strategies has likely come as something of a relief for those companies operating i…
…
continue reading
1
Pharma and Biotech Daily: Top Stories from the Industry
0:56
0:56
Play later
Play later
Lists
Like
Liked
0:56
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. President Trump has once again delayed the imposition of 100% tariffs on pharmaceuticals, with preparations now set to begin on October 1. Halozyme's acquisition of Elektrofi for $900 million has brought two major pharma…
…
continue reading
1
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
44:49
44:49
Play later
Play later
Lists
Like
Liked
44:49
Raising money in the gene therapy space can be tough right now but, for the right company and with the right team, there is still cash to be found. But how do you connect with investors, how do you get your science in front of the right people, and how do you move from ‘I’m interested’ to ‘I’m signing on the dotted line’? This week I talk with Gera…
…
continue reading
1
Digital Health Talks: From Compliance to Confidence On How to Evolve Cybersecurity
28:23
28:23
Play later
Play later
Lists
Like
Liked
28:23
From Compliance to Confidence: How to Evolve Cybersecurity Beyond the ChecklistHealthcare cybersecurity stands at an inflection point. Traditional compliance frameworks are proving inadequate in the face of sophisticated threats targeting patient data, clinical operations, and connected medical devices. Robert Eikel, CISO at P-n-T Data Corp., bring…
…
continue reading
1
372: A pharma C-suite shakeup and Trump's deal with Pfizer
28:05
28:05
Play later
Play later
Lists
Like
Liked
28:05
How will we look back on Emma Walmsley's tenure as GSK's CEO? Why did one of the FDA's top drug officials call out an obscure lupus drug on LinkedIn? And will we ever stop talking about the pharma patent cliff? Adam is out this week, so Allison and Elaine dive into the latest news, starting with another biotech acquisition and a new CEO at GSK. The…
…
continue reading
1
#38 - Where Sleep Meets Strategy: Inside Eight Sleep’s Data-Driven Growth | Nick Chammas
36:54
36:54
Play later
Play later
Lists
Like
Liked
36:54
Share your thoughts with us! At Eight Sleep, product innovation isn’t just about comfort—it’s about performance, health, and personalization at scale. And behind the numbers powering that mission is CFO Nick Chammas. On this episode of Ventured Growth, Catherine Jhung sits down with Nick to discuss how Eight Sleep evolved from a niche product for a…
…
continue reading
1
Pharma and Biotech Daily: Navigating Industry Shifts and Emerging Trends
1:48
1:48
Play later
Play later
Lists
Like
Liked
1:48
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer's recent deal with the Trump administration regarding drug pricing has sparked concerns about access to medications, particularly with a focus on commitments to manufacturing in the U.S. and tariff exemptions. The …
…
continue reading
Welcome back to the Ennovation Podcast, where we bring you the latest trends, insights, and expertise in life sciences and regulatory affairs. This time, we're joined by Michiel Stam, management consultant and regulatory lead at MAIN5, to explore what it really takes to prepare for EMA’s PMS data enrichment deadlines. Michiel’s top resources: Take …
…
continue reading
1
Pharma and Biotech Daily: Metsera's Mid-Stage Success, AI in Drug Production, and GSK's CEO Resignation
1:12
1:12
Play later
Play later
Lists
Like
Liked
1:12
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Metsera's mid-stage obesity drug, met-097i, has shown "very encouraging" efficacy, supporting Pfizer's proposed $4.9 billion buyout of the company. The drug's performance is seen as positive by BMO Capital Markets. In ot…
…
continue reading
